Status:
COMPLETED
Trial Comparing Metabolic Effects of Telmisartan and Amlodipine on Hypertensive Patients With Obesity and Diabetes
Lead Sponsor:
Third Military Medical University
Conditions:
Hypertension
Obesity
Eligibility:
All Genders
30-70 years
Phase:
PHASE4
Brief Summary
Recent studies have shown that obese people are more prone to high blood pressure. With the co-existence of obesity, hypertension and diabetes, patients were more susceptible to hyperlipidemia, corona...
Eligibility Criteria
Inclusion
- Information Consent Signed
- Aged 30\~70 years
- For whom without anti-hypertensive therapy in 2 weeks：140mmHg≤SBP\<180mmHg，或90mmHg≤DBP\<110mmHg. For whom with anti-hypertensive therapies in 2 weeks：SBP\<180mmHg, 且DBP\<110mmHg
- Waist circumference higher than 90cm in men, 80cm in women
- Diagnosed diabetes
Exclusion
- Grade 3 hypertension: SBP≥180mmHg, or DBP≥110mmHg
- Waist circumference less than 90cm in men, 80cm in women
- Known allergy or hypersensitivity to trial drugs
- NYHA grade Ⅱ\~Ⅳ heart failure, Myocardial infarction or cerebrovascular accident in 1 year preceding the trial
- Acute infections, tumor, severe arrhythmia, mental disease, drug or alcohol abuse
- History of hepatitis or cirrhosis
- History of severe kidney disease
- Pregnant, lactation
- Enrolled in other trials in 3 months
- Any obstacles of follow-up or compliance
Key Trial Info
Start Date :
June 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2009
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT00847262
Start Date
June 1 2008
End Date
June 1 2009
Last Update
December 17 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The third hospital affiliated to the Third Military Medical University
Chongqing, China, 400042